skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Informa pharma logo

Pharma Intelligence is part of the Informa Intelligence Division of Informa PLC

This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Pharma Intelligence Logo
Search Icon Pharma Report StoreRecommendationsProduct loginProductLogin
Global Search Configuration

Find out who’s leading the pack in Oncology drug development, and take a closer look at where the highest success rates are by viewing our webinar recording on Oncology Success Rates. 

 

Effectively manage your portfolio risk by using the comprehensive data sets, including Probability of Overall Success (POS), Likelihood of Approval (LOA), and Phase and Overall Duration, in Pharmapremia. Covering over 500 indications and 7,000 programs, including over 2,200 in oncology, Pharmapremia allows you to generate customized intelligence reports tailored to your company’s goals and needs.

Watch the recording below today!

Read also

  • Awareness, Pharmaceutical Consulting

    Hunting for Cancer Neoantigens : What is the best approach?

    Important insights into neoantigen-based immunotherapies and which developers are leading in this growing area.

    Topics Cancer Clinical Trial Optimization

    View white paper

  • In Vivo: strategic insights for life sciences decision-maker...

    A Tale Of Two Pipelines

    Immuno-oncology has produced some exciting successes, but the field has become intensely crowded. Enormous resources are being poured into duplicative work and shaky hypotheses—overshadowing other pursuits in cancer research while producing limited results. It is time to re-evaluate how the sector should be pursuing innovation in cancer and how it can be smarter in its use of resources—financial investment, talent, bandwidth, patients and data.

    Topics Cancer Research & Development

    View Analysis
;

Next steps

Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.

Request live demo now:

Request a free demo

Our team is always happy to hear from you. Please call us at:

  • US Toll-Free  : +1 888 670 8900
  • US Toll           : +1 908 547 2200
  • UK & Europe : +44 (20) 337 73737
  • Australia        : +61 2 8705 6907
  • Japan              : +81 3 6273 4260

Or please submit your inquiry via the form so that we can provide you the best possible customer service.
General enquiry

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now:

Shop now